Literature DB >> 35435946

Mechanism of use-dependent Kv2 channel inhibition by RY785.

Matthew James Marquis1, Jon T Sack1,2.   

Abstract

Understanding the mechanism by which ion channel modulators act is critical for interpretation of their physiological effects and can provide insight into mechanisms of ion channel gating. The small molecule RY785 is a potent and selective inhibitor of Kv2 voltage-gated K+ channels that has a use-dependent onset of inhibition. Here, we investigate the mechanism of RY785 inhibition of rat Kv2.1 (Kcnb1) channels heterologously expressed in CHO-K1 cells. We find that 1 µM RY785 block eliminates Kv2.1 current at all physiologically relevant voltages, inhibiting ≥98% of the Kv2.1 conductance. Both onset of and recovery from RY785 inhibition require voltage sensor activation. Intracellular tetraethylammonium, a classic open-channel blocker, competes with RY785 inhibition. However, channel opening itself does not appear to alter RY785 access. Gating current measurements reveal that RY785 inhibits a component of voltage sensor activation and accelerates voltage sensor deactivation. We propose that voltage sensor activation opens a path into the central cavity of Kv2.1 where RY785 binds and promotes voltage sensor deactivation, trapping itself inside. This gated-access mechanism in conjunction with slow kinetics of unblock supports simple interpretation of RY785 effects: channel activation is required for block by RY785 to equilibrate, after which trapped RY785 will simply decrease the Kv2 conductance density.
© 2022 Marquis and Sack.

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 35435946      PMCID: PMC9195051          DOI: 10.1085/jgp.202112981

Source DB:  PubMed          Journal:  J Gen Physiol        ISSN: 0022-1295            Impact factor:   4.000


  92 in total

1.  Identification of the Kv2.1 K+ channel as a major component of the delayed rectifier K+ current in rat hippocampal neurons.

Authors:  H Murakoshi; J S Trimmer
Journal:  J Neurosci       Date:  1999-03-01       Impact factor: 6.167

2.  Potassium channel receptor site for the inactivation gate and quaternary amine inhibitors.

Authors:  M Zhou; J H Morais-Cabral; S Mann; R MacKinnon
Journal:  Nature       Date:  2001-06-07       Impact factor: 49.962

3.  Immunological identification and characterization of a delayed rectifier K+ channel polypeptide in rat brain.

Authors:  J S Trimmer
Journal:  Proc Natl Acad Sci U S A       Date:  1991-12-01       Impact factor: 11.205

4.  Molecular determinants of dofetilide block of HERG K+ channels.

Authors:  E Ficker; W Jarolimek; J Kiehn; A Baumann; A M Brown
Journal:  Circ Res       Date:  1998-02-23       Impact factor: 17.367

5.  Closed state-coupled C-type inactivation in BK channels.

Authors:  Jiusheng Yan; Qin Li; Richard W Aldrich
Journal:  Proc Natl Acad Sci U S A       Date:  2016-06-13       Impact factor: 11.205

6.  Local anesthetics: hydrophilic and hydrophobic pathways for the drug-receptor reaction.

Authors:  B Hille
Journal:  J Gen Physiol       Date:  1977-04       Impact factor: 4.086

7.  Kv2.1 Potassium Channels Regulate Repetitive Burst Firing in Extratelencephalic Neocortical Pyramidal Neurons.

Authors:  Greg S Newkirk; Dongxu Guan; Nikolai Dembrow; William E Armstrong; Robert C Foehring; William J Spain
Journal:  Cereb Cortex       Date:  2022-02-19       Impact factor: 4.861

8.  The external TEA binding site and C-type inactivation in voltage-gated potassium channels.

Authors:  Payam Andalib; Joseph F Consiglio; Josef G Trapani; Stephen J Korn
Journal:  Biophys J       Date:  2004-08-23       Impact factor: 4.033

9.  AMIGO-Kv2.1 Potassium Channel Complex Is Associated With Schizophrenia-Related Phenotypes.

Authors:  Marjaana A Peltola; Juha Kuja-Panula; Johanna Liuhanen; Vootele Võikar; Petteri Piepponen; Tero Hiekkalinna; Tomi Taira; Sari E Lauri; Jaana Suvisaari; Natalia Kulesskaya; Tiina Paunio; Heikki Rauvala
Journal:  Schizophr Bull       Date:  2015-08-03       Impact factor: 9.306

10.  Epilepsy and neurobehavioral abnormalities in mice with a dominant-negative KCNB1 pathogenic variant.

Authors:  Nicole A Hawkins; Sunita N Misra; Manuel Jurado; Seok Kyu Kang; Nicholas C Vierra; Kimberly Nguyen; Lisa Wren; Alfred L George; James S Trimmer; Jennifer A Kearney
Journal:  Neurobiol Dis       Date:  2020-10-22       Impact factor: 5.996

View more
  1 in total

1.  A Kv2 inhibitor traps itself in place.

Authors:  Ben Short
Journal:  J Gen Physiol       Date:  2022-05-06       Impact factor: 4.000

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.